Skip to content
Michael Lachman

Michael Lachman

Contributing Writer

Michael Lachman is President of EyeQ Research, which provides market research, analytics, and strategic advisory to ophthalmic companies and investors. Previously, he was a healthcare investment research analyst with Hambrecht & Quist, ThinkEquity Partners, and SAC Capital, and worked in business development, marketing, and R&D for Johnson & Johnson and Baxter.

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma
OIS Index Posts a Strong Finish to 2019

OIS Index Posts a Strong Finish to 2019

The OIS Index of ophthalmic stocks made a strong comeback in Q4-2019, following a rough Q3. The index gained 16.2% in Q4, slightly underperforming the ...
Read More
OIS Index Outperforms

OIS Index Outperforms

The OIS Index of ophthalmic stocks gained 5.4% in November, following a similar 5.2% gain in October. The index outperformed medical device stocks (+4.3%) and ...
Read More
OIS Index Nov. 2019

OIS Index on Positive Upswing

The OIS Index of ophthalmic stocks gained 5.2% in October, posting its first month of positive performance since June. The index lagged the biotech sector ...
Read More
OIS Index Deep in Bear Territory in Q3

OIS Index Deep in Bear Territory in Q3

The OIS Index of ophthalmic stocks posted a miserable Q3 performance, led by the biopharmaceutical stocks in the index. The OIS Index (-12.0%) underperformed the ...
Read More
OIS Index Q2 2019

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

The OIS Index of ophthalmic stocks posted a modest positive return of +0.8% during the second quarter of 2019. The index outperformed the NASDAQ Biotechnology ...
Read More
OIS Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

The OIS Index of ophthalmic stocks solidly outperformed its market benchmarks in the first quarter of 2019, gaining 37.1%. During Q1, the overall US stock ...
Read More
OIS Index Follows the Stock Market Lower in December

OIS Index Follows the Stock Market Lower in December

The OIS Index declined 11% in December, marking the fourth month in a row in which ophthalmic stocks lost value. For the month, the overall ...
Read More
OIS Index

Market Rebounds in November; OIS Index Does Not

The OIS Index of ophthalmic stocks declined by 2.3% in November on the heels of a 17.7% decline in October, failing to participate in the ...
Read More
OIS Index

OIS Index Follows Stock Market Lower in October

The OIS Index of ophthalmic stocks declined by 17.7% during the October market correction, which saw a 7.5% decline in the overall US stock market ...
Read More
Small Cap Stocks Lead the Way for OIS Index in September

Small Cap Stocks Lead the Way for OIS Index in September

The OIS Index of ophthalmic stocks gave back some of its recent gains in September, declining by 4.1% against an overall flat market backdrop. The ...
Read More
OIS Index Follows the Stock Market Lower in December

Glaukos and STAAR Drive OIS Index into Record Territory

The OIS Index of ophthalmic stocks surged to new highs in August, driven by two of the highest-weighted stocks in the index. The OIS Index ...
Read More
OIS Index

OIS Index Lags Market Benchmarks in July

The OIS Index of ophthalmic stocks declined by 1.1% in July, against a strong overall market backdrop. During the month, the overall US stock market ...
Read More
Scroll To Top